Why the study?
Does immunoadsorption improve cardiac function in patients with dilated cardiomyopathy?
Population
Patients with dilated cardiomyopathy (DCM)
Design
Review
Authors
Loading...
May support immunoadsorption in DCM; leaves open confirmation by randomized trials.
Does immunoadsorption improve cardiac function in patients with dilated cardiomyopathy?
Immunoadsorption represents a potential therapeutic option for dilated cardiomyopathy by removing cardiodepressive autoantibodies and improving cardiac function.
Felix et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: